What is Kura Oncology's gross profit?

Kura Oncology (KURA) reported gross profit of $18M in Q1 2026.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Kura Oncology KURA Gross Profit

Gross Profit at other companies

Johnson & JohnsonJNJ

$15.96B+9.8%

AmgenAMGN

$5.87B+13.4%

AbbVieABBV

$10.78B+15.4%

Vertex PharmaceuticalsVRTX

$2.59B+7.8%

ExelixisEXEL

——

IncyteINCY

——

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+86.2%

Enterprise value$927.97M+95.5%

P/S13.2×+3.9×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Calculated from Kura Oncology’s reported figures.

$18.3Mtotal revenue−$262.0Ktotal cost of revenue=$18M

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's gross profit?: Kura Oncology (KURA) reported gross profit of $18M in Q1 2026.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.